Status:
UNKNOWN
Disease Loads and Status of Treatment
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Chronic Hepatitis B
Acute Hepatitis B
Eligibility:
All Genders
Brief Summary
The aim of study is to evaluate the current prevalence of HDV infection, and comprehensively analyze the interaction between HDV and HBV infections in the era of NAs in Taiwan. Investigators plan to s...
Detailed Description
Background The hepatitis Delta virus (HDV) was first discovered by Rizzetto at the end of the 1970s while a cohort of patients with hepatitis B virus (HBV) presented in Italy with severe hepatitis. HD...
Eligibility Criteria
Inclusion
- Chronic HBV
- Acute HBV
- anti-HDV positive
Exclusion
- Other diagnostics deemed not suitable for this study by the principal investigator
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05264272
Start Date
January 1 2022
End Date
December 1 2024
Last Update
March 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100